Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Low-dose warfarin reported to prevent recurrent venous thromboembolism

March 4, 2003

CPMP recommends removal of contraindication for i.v. fibrinolytic use in diabetic patients

March 4, 2003

Broad-spectrum antithrombotic properties described for SSR-182289A

Feb. 28, 2003

Nuvelo reveals alfimeprase program progress in 2002

Feb. 27, 2003

New PAI-1 inhibitors in early development at Tanabe Seiyaku

Feb. 27, 2003

Encouraging results obtained for Exanta in prevention of stroke in atrial fibrillation

Feb. 20, 2003

Merck designs new factor Xa and/or factor VIIa inhibitors

Feb. 20, 2003

Aventis claims novel factor VIIa inhibitors

Feb. 19, 2003

Dual TXA2/5-HT2 antagonists prepared and tested by Servier research team

Feb. 17, 2003

Eptacog alfa in intracerebral hemorrhage

Feb. 13, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.